Ultrasound and Psychobiological Correlates of Female Sexual Function

Sponsor
University of Florence (Other)
Overall Status
Unknown status
CT.gov ID
NCT02372643
Collaborator
(none)
20
1
1
65.9
0.3

Study Details

Study Description

Brief Summary

Monocentric pilot interventional study. The aim of the study is to assess clitoral doppler ultrasonographic parameters in a population of sexually healthy volunteer women in order to obtain reference values. Psychobiological correlates of female sexual function will also be studied through hormonal testing and psychological evaluation.

Condition or Disease Intervention/Treatment Phase
  • Other: clitoral, transvaginal and transrectal ultrasound
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Pilot Interventional Study on Clitoral Ultrasound Measures and Psychobiological Correlates of Female Sexual Function
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Dec 31, 2019
Anticipated Study Completion Date :
Jun 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Sexually healthy women

20 sexually healthy volunteer women will be enrolled from subjects consulting our outpatient clinic (subjects free from sexual dysfunction). Hormonal and ultrasound parameters and self-administered questionnaires will be evaluated.

Other: clitoral, transvaginal and transrectal ultrasound
Doppler Ultrasound assessment of clitoral hemodynamics will be performed in all subjects. Transvaginal and transrectal ultrasound will be performed in subjects giving their consent to these procedures.

Outcome Measures

Primary Outcome Measures

  1. Clitoral artery peak systolic velocity and acceleration [baseline]

    This will not be evaluated in different time frames but evaluated in order to assess reference values in sexually healthy women and compared with subjects with sexual dysfunction.

Secondary Outcome Measures

  1. Female sexual function assessed through the Female Sexual Function Index (FSFI) [baseline]

  2. General psychopathology assessed through the Middlesex Hospital Questionnaire (MHQ) [baseline]

    See above

  3. Body image is investigated through the Body Uneasiness Test (BUT) [baseline]

  4. Measurement of the thickness of the urethrovaginal space [baseline]

  5. Measurement of the thickness of the endometrial lining [baseline]

  6. Hormonal parameters (17β-estradiol, total testosterone, LH, FSH, TSH, PRL, delta-4-androstenedione, DHEAS, 17-Hydroxyprogesterone, SHBG) [baseline]

  7. Metabolic parameters (total cholesterol, HDL, triglycerides, glycemia, insulin, glycated hemoglobin) [baseline]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • sexually healthy

  • evidence of a personally signed and dated informed consent.

Exclusion Criteria:
  • any uncontrolled or unstable, acute or chronic disease

  • alcohol or drugs abuse

  • sexual dysfunction

  • any overt psychiatric or psychological condition assessed through psychological evaluation and/or self-administered validated questionnaires.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ambulatori di Medicina della SessualitĂ  e Andrologia Florence Italy

Sponsors and Collaborators

  • University of Florence

Investigators

  • Principal Investigator: Mario Maggi, University of Florence

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mario Maggi, Full Professor of Endocrinology, University of Florence
ClinicalTrials.gov Identifier:
NCT02372643
Other Study ID Numbers:
  • ANDRO-AOUC-2015-01
First Posted:
Feb 26, 2015
Last Update Posted:
Mar 26, 2020
Last Verified:
Mar 1, 2020

Study Results

No Results Posted as of Mar 26, 2020